Peroxisome proliferator-activated receptors (PPARs) and their role in the vessel wall: possible mediators of cardiovascular risk?
- PMID: 11550998
- DOI: 10.1177/174182670100800404
Peroxisome proliferator-activated receptors (PPARs) and their role in the vessel wall: possible mediators of cardiovascular risk?
Abstract
Peroxisome proliferator-activated receptors (PPARs) are nuclear transcription factors that regulate gene expression in response to activation by specific ligands including insulin sensitizing thiazolidinedione and lipid-lowering fibrates. Recent work has identified PPARalpha and PPARgamma expression in vascular cells and established a role for these receptors in the regulation of genes relevant to atherogenesis. The following review will focus on the role of PPAR activation in the vasculature and discuss the potential clinical implications of these findings.
Comment in
-
Overview. PPAR and cardiovascular risk.J Cardiovasc Risk. 2001 Aug;8(4):185-6. J Cardiovasc Risk. 2001. PMID: 11550995 No abstract available.
Similar articles
-
Peroxisome proliferator-activated receptors and atherogenesis: regulators of gene expression in vascular cells.Circ Res. 2004 May 14;94(9):1168-78. doi: 10.1161/01.RES.0000127122.22685.0A. Circ Res. 2004. PMID: 15142970 Review.
-
Peroxisome proliferator-activated receptors (PPARs): nuclear receptors with functions in the vascular wall.Z Kardiol. 2001;90 Suppl 3:125-32. doi: 10.1007/s003920170034. Z Kardiol. 2001. PMID: 11374025 Review.
-
[Peroxisome proliferator-activated receptors (PPAR) in pathophysiology of the circulatory system and prospective use of agonists of these receptors in therapy].Postepy Hig Med Dosw. 2003;57(2):199-217. Postepy Hig Med Dosw. 2003. PMID: 12866356 Review. Polish.
-
Peroxisome proliferator-activated receptors (PPARs): nuclear receptors at the crossroads between lipid metabolism and inflammation.Inflamm Res. 2000 Oct;49(10):497-505. doi: 10.1007/s000110050622. Inflamm Res. 2000. PMID: 11089900 Review.
-
[Peroxisome proliferator-activated receptors (PPARs) in the vessel wall: new regulators of gene expression in vascular cells].Z Kardiol. 2001 Jul;90(7):470-7. doi: 10.1007/s003920170135. Z Kardiol. 2001. PMID: 11515276 Review. German.
Cited by
-
Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance.J Clin Invest. 2003 Dec;112(12):1821-30. doi: 10.1172/JCI19451. J Clin Invest. 2003. PMID: 14679177 Free PMC article.
-
Obesity-related upregulation of monocyte chemotactic factors in adipocytes: involvement of nuclear factor-kappaB and c-Jun NH2-terminal kinase pathways.Diabetes. 2009 Jan;58(1):104-15. doi: 10.2337/db07-1344. Epub 2008 Oct 3. Diabetes. 2009. PMID: 18835938 Free PMC article.
-
Lipaemia, inflammation and atherosclerosis: novel opportunities in the understanding and treatment of atherosclerosis.Drugs. 2004;64 Suppl 2:19-41. doi: 10.2165/00003495-200464002-00004. Drugs. 2004. PMID: 15765889 Review.
-
PREMATURE VASCULAR SENESCENCE IN METABOLIC SYNDROME: COULD IT BE PREVENTED AND REVERSED BY A SELENORGANIC ANTIOXIDANT AND PEROXYNITRITE SCAVENGER EBSELEN?Drug Discov Today Ther Strateg. 2007;4(1):93-99. doi: 10.1016/j.ddstr.2007.10.006. Drug Discov Today Ther Strateg. 2007. PMID: 18496595 Free PMC article. No abstract available.
-
Inhibition of MMP-9 expression by PPARgamma activators in human bronchial epithelial cells.Thorax. 2003 Sep;58(9):778-83. doi: 10.1136/thorax.58.9.778. Thorax. 2003. PMID: 12947137 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources